Evercore ISI Increases Intuitive Surgical (NASDAQ:ISRG) Price Target to $530.00

Intuitive Surgical (NASDAQ:ISRG) had its price target increased by Evercore ISI from $490.00 to $530.00 in a research note issued to investors on Monday.

A number of other research firms have also commented on ISRG. Morgan Stanley raised Intuitive Surgical from an “equal weight” rating to an “overweight” rating and upped their price target for the company from $522.00 to $650.00 in a research report on Monday, December 2nd. Piper Sandler reissued an “overweight” rating and set a $670.00 price objective (up from $538.00) on shares of Intuitive Surgical in a research report on Friday, January 24th. BTIG Research lifted their price objective on Intuitive Surgical from $535.00 to $561.00 and gave the company a “buy” rating in a research report on Tuesday, November 26th. Wells Fargo & Company boosted their price target on Intuitive Surgical from $630.00 to $687.00 and gave the stock an “overweight” rating in a research report on Friday, January 24th. Finally, Stifel Nicolaus raised their price target on shares of Intuitive Surgical from $525.00 to $610.00 and gave the company a “buy” rating in a research report on Thursday, December 5th. One equities research analyst has rated the stock with a sell rating, five have issued a hold rating and sixteen have assigned a buy rating to the company. According to MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and an average price target of $613.10.

Intuitive Surgical Trading Down 0.2 %

ISRG stock opened at $572.71 on Monday. The stock has a market capitalization of $203.99 billion, a price-to-earnings ratio of 92.08, a PEG ratio of 5.19 and a beta of 1.39. The firm’s 50-day moving average price is $548.70 and its two-hundred day moving average price is $507.04. Intuitive Surgical has a 12-month low of $364.17 and a 12-month high of $616.00.

Insiders Place Their Bets

In other Intuitive Surgical news, CFO Jamie Samath sold 94 shares of the stock in a transaction on Wednesday, January 29th. The stock was sold at an average price of $571.11, for a total value of $53,684.34. Following the completion of the sale, the chief financial officer now owns 2,630 shares in the company, valued at approximately $1,502,019.30. This represents a 3.45 % decrease in their position. The sale was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, Director Amal M. Johnson sold 4,635 shares of the stock in a transaction dated Tuesday, January 28th. The stock was sold at an average price of $566.60, for a total value of $2,626,191.00. Following the sale, the director now owns 12,275 shares of the company’s stock, valued at $6,955,015. This represents a 27.41 % decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 28,843 shares of company stock worth $15,357,560 over the last quarter. 0.90% of the stock is currently owned by corporate insiders.

Institutional Investors Weigh In On Intuitive Surgical

Several institutional investors and hedge funds have recently modified their holdings of ISRG. State Street Corp grew its stake in Intuitive Surgical by 1.4% during the third quarter. State Street Corp now owns 15,050,121 shares of the medical equipment provider’s stock valued at $7,393,673,000 after acquiring an additional 210,363 shares in the last quarter. FMR LLC grew its position in shares of Intuitive Surgical by 8.3% during the third quarter. FMR LLC now owns 10,971,085 shares of the medical equipment provider’s stock valued at $5,389,765,000 after purchasing an additional 838,793 shares in the last quarter. Geode Capital Management LLC increased its holdings in shares of Intuitive Surgical by 1.9% in the third quarter. Geode Capital Management LLC now owns 7,512,925 shares of the medical equipment provider’s stock worth $3,677,194,000 after purchasing an additional 143,440 shares during the last quarter. Fisher Asset Management LLC lifted its position in shares of Intuitive Surgical by 1.8% in the third quarter. Fisher Asset Management LLC now owns 4,782,381 shares of the medical equipment provider’s stock worth $2,349,441,000 after buying an additional 86,208 shares in the last quarter. Finally, Baillie Gifford & Co. boosted its stake in Intuitive Surgical by 0.6% during the third quarter. Baillie Gifford & Co. now owns 3,848,547 shares of the medical equipment provider’s stock valued at $1,890,676,000 after buying an additional 24,183 shares during the last quarter. Institutional investors own 83.64% of the company’s stock.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.